• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Hormone substitution in postmenopause. Administration mode, regimen and compliance].

作者信息

Keller P J

机构信息

Klinik für Endokrinologie, Department Frauenheilkunde Universitätsspital Zürich, Schweiz.

出版信息

Zentralbl Gynakol. 1997;119(6):260-4.

PMID:9312960
Abstract

The route of administration and the regimen are of great importance for efficacy and acceptance of hormone replacement therapy in the menopause. Steroids may be applied orally, transdermally, subcutaneously or vaginally. Due to the differences in absorption and metabolization the serum levels are very variable. Bone and heart protection are secured by either oral or parenteral application. Unopposed estrogens should be given to hysterectomized women only, except estriol. In all the other patients progestogens must be added, preferably for 10-14 days per month. Prolonged intervals of up to three months are acceptable in selected cases. A few years after menopause continuous-combines regimen may be used in order to prevent withdrawal bleeds. The choice of the method is also decisive for compliance, since side effects, particularly irregular bleedings are among the most frequent causes for discontinuation. Counseling, motivation and comprehensive care are equally important.

摘要

相似文献

1
[Hormone substitution in postmenopause. Administration mode, regimen and compliance].
Zentralbl Gynakol. 1997;119(6):260-4.
2
The importance of patient education in improving compliance.
Climacteric. 2000 Dec;3 Suppl 2:9-13.
3
Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.更年期医学中的争议问题II. 激素替代疗法与癌症。国际绝经学会专家研讨会。2001年6月9日至12日,意大利比萨大教堂歌剧院
Climacteric. 2001 Sep;4(3):181-93.
4
Hormone replacement therapy and cancer.激素替代疗法与癌症。
Gynecol Endocrinol. 2001 Dec;15(6):453-65.
5
[Hormone substitution in menopause].[更年期的激素替代疗法]
Praxis (Bern 1994). 1997 Sep 17;86(38):1458-62.
6
Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.用于激素替代疗法和避孕的性类固醇经皮给药。原理与实践综述。
J Reprod Med. 2003 Jul;48(7):525-40.
7
Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.绝经后激素替代疗法延续性的比较:经皮雌激素与口服雌激素
Menopause. 1998 Fall;5(3):152-6.
8
Comparative cardiovascular effects of different progestins in menopause.不同孕激素在绝经后对心血管系统的比较影响
Int J Fertil Womens Med. 2001 Sep-Oct;46(5):248-56.
9
[Estrogens following menopause. Methods of hormone replacement].[绝经后的雌激素。激素替代方法]
Rev Med Brux. 1995 Jul-Aug;16(4):291-4.
10
Hormone replacement therapy in postmenopausal women.绝经后女性的激素替代疗法。
J Med Invest. 2003 Aug;50(3-4):136-45.